Q waves and coronary arteriography in cardiomyopathy.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 458543)

Published in Br Heart J on October 01, 1972

Authors

G T Gau, J F Goodwin, C M Oakley, E G Olsen, S H Rahimtoola, M J Raphael, R E Steiner

Articles by these authors

Career prospects in cardiology in England and Wales. Survey and 15 health regions. Br Heart J (1981) 8.82

Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19

Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33

Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med (1994) 4.83

Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA (2000) 4.51

Natural course of peripartum cardiomyopathy. Circulation (1971) 3.60

The microbiology and pathogenesis of infective endocarditis. Br Heart J (1983) 3.36

The cardiomyopathies. Br Heart J (1972) 3.14

Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation (1998) 2.97

Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol (2000) 2.93

Hypertrophic obstructive cardiomyopathy, a histological, histochemical, and ultrastructural study of biopsy material. Cardiovasc Res (1971) 2.84

Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease. Br Heart J (1977) 2.68

Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet (1986) 2.68

Acute subvalvar mitral incompetence. Lancet (1966) 2.65

Blood-gas changes after acute myocardial infarction. Lancet (1966) 2.61

Coronary heart disease in situs inversus totalis. Am J Cardiol (1973) 2.55

The problem of valve prosthesis-patient mismatch. Circulation (1978) 2.47

Peripartum cardiomyopathy. Circulation (1971) 2.47

Therapeutic defibrination in the treatment of thrombotic disease. Lancet (1968) 2.40

Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus. Lancet (1991) 2.36

An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med (1991) 2.27

Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet (1994) 2.25

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J (1985) 2.22

Imaging of the brain by nuclear magnetic resonance. Lancet (1981) 2.19

Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. Br Heart J (1977) 2.18

Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet (1973) 2.04

Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03

Regression of primary pulmonary hypertension. Br Heart J (1976) 2.03

Acute rheumatic fever and carditis in older adults. Lancet (1966) 2.01

The frontiers of cardiomyopathy. Br Heart J (1982) 1.98

Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet (1987) 1.98

Angina pectoris with normal coronary arteries. Transvenous myocardial biopsy in diagnosis. Lancet (1974) 1.97

Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med (1983) 1.96

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation (1990) 1.96

Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 1.95

A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation (1985) 1.93

Endomyocardial fibrosis in Europeans resident in tropical Africa. Lancet (1967) 1.93

Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation (1990) 1.91

Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J (1981) 1.91

Eosinophilia and heart disease. Br Heart J (1977) 1.90

Echocardiography and pathology of left ventricular "false tendons". Chest (1990) 1.88

Infective endocarditis. Br J Hosp Med (1980) 1.88

Prospects and predictions for the cardiomyopathies. Circulation (1974) 1.87

Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J (1979) 1.86

Echocardiography of the mitral valve in aortic valve disease. Br Heart J (1971) 1.86

Effects of surgical closure of ventricular septal defects upon pulmonary vascular disease. Br Heart J (1969) 1.86

The natural course of alcoholic cardiomyopathy. Ann Intern Med (1974) 1.85

Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med (1973) 1.85

Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet (1981) 1.84

ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis (1998) 1.83

Assessment of site and severity in congenital aortic stenosis. Br Heart J (1967) 1.83

Right ventricular dilated cardiomyopathy. Br Heart J (1984) 1.74

The spectrum of cardiac tumors. Am J Cardiol (1968) 1.72

M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J Cardiol (1980) 1.72

Novel risk factors for atherosclerosis. Mayo Clin Proc (2000) 1.70

Medical and economic costs of psychologic distress in patients with coronary artery disease. Mayo Clin Proc (1995) 1.70

Cadiovascular complications of homozygous familial hypercholesterolaemia. Br Heart J (1980) 1.69

Jaundice after Transfusion of Whole Blood or Human Plasma. Br Med J (1944) 1.69

The hemodynamics of common (or single) ventricle. Circulation (1966) 1.69

Coronary bypass for stable angina: a prospective randomized study. N Engl J Med (1979) 1.68

Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol (1992) 1.66

Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet (1992) 1.65

Myocardial bridges: morphological and functional aspects. Br Heart J (1991) 1.64

Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J (1979) 1.64

Initial clinical evaluation of a whole body nuclear magnetic resonance (NMR) tomograph. J Comput Assist Tomogr (1982) 1.63

Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J (1971) 1.63

Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis (1985) 1.63

Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med (1983) 1.62

The bowel, the genitourinary tract, and infective endocarditis. Br Heart J (1984) 1.62

Pathology of primary cardiomyopathies. Postgrad Med J (1972) 1.61

Clinical NMR imaging of the brain: 140 cases. AJR Am J Roentgenol (1982) 1.61

Congenital fistula between the aorta and left atrium. Br Heart J (1987) 1.61

Left ventricular angiography on exercise. A new method of assessing left ventricular function in ischaemic heart disease. Br Heart J (1976) 1.60

Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J (1994) 1.59

Pseudo A-V block secondary to premature nonpropagated His bundle depolarizations: documentation by His bundle electrocardiography. Circulation (1970) 1.58

Chagas' heart disease in the United States. N Engl J Med (1991) 1.56

Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy. Br Med J (1968) 1.56

The prognosis of patients with coronary artery disease after coronary bypass operations. Time-related progress of 532 patients with disabling angina pectoris. Circulation (1974) 1.56

Inability of the ST segment/heart rate slope to predict accurately the severity of coronary artery disease. Br Heart J (1984) 1.56

Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. I: Morphological and morphometric aspects. Br Heart J (1981) 1.54

Niacin-induced hepatitis: a potential side effect with low-dose time-release niacin. Mayo Clin Proc (1991) 1.54

Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J (2000) 1.54

Cine angiography of left ventricular aneurysms. Clin Radiol (1972) 1.53

Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Br Med J (1966) 1.53